Mitaka, Japan

Yumiko Takita

This inventor holds 1 USPTO granted patent. Top assignee: Chugai Seiyaku Kabushiki Kaisha. Active years: 1991.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yumiko Takita. Retrieved from https://idiyas.com/inventor/yumiko-takita

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 25(Granted Patents)


Company Filing History:


Years Active: 1991

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yumiko Takita: Innovator in Hyperparathyroidism Treatment

Introduction

Yumiko Takita is a notable inventor based in Mitaka, Japan. She has made significant contributions to the field of medicine, particularly in the treatment of hyperparathyroidism. Her innovative approach utilizes vitamin D derivatives to provide therapeutic solutions for this condition.

Latest Patents

Yumiko Takita holds 1 patent for her work titled "Treatment for hyperparathyroidism with use of vitamin D derivatives." This patent describes a treatment method involving a 1.alpha.-hydroxyvitamin D derivative, which is effective in managing hyperparathyroidism, including secondary hyperparathyroidism. The pharmaceutical composition she developed comprises derivatives that are beneficial as therapeutic agents.

Career Highlights

Yumiko Takita is associated with Chugai Seiyaku Kabushiki Kaisha, a prominent pharmaceutical company in Japan. Her work at this institution has been pivotal in advancing treatment options for patients suffering from hyperparathyroidism.

Collaborations

Yumiko collaborates with Yasuho Nishii, who is also a key figure in her research endeavors. Their partnership has contributed to the development of innovative treatments in their field.

Conclusion

Yumiko Takita's contributions to the treatment of hyperparathyroidism highlight her role as an influential inventor in the medical field. Her innovative use of vitamin D derivatives showcases the potential for advancements in therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…